Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • vivek_
    PhD Student
    • Jul 2012
    • 164

    #1

    Identifying de novo variants in trio data

    I have trio datasets that I have phased using GATK's PhaseByTransmission and ReadbackedPhasing walkers.

    My target is to identify de novo mutations from this data.

    I'm creating a candidate de novo mutations dataset by checking for variants that are present in the offspring and not in either of the parents as well as looking for variant sites where there are mendelian violations.

    I'd like to know how to proceed in filtering through this dataset to confidently ascertain variants that are de novo from the rest.

    I'd appreciate any inputs/ideas on creating a methodology to go about this analysis.
  • rosa_dentellare
    Member
    • Sep 2011
    • 10

    #2
    Hi Vivek,

    did u managed to find a way to proceed with the analysis?
    HTML Code:
    <a href="http://www.mylivesignature.com" target="_blank"><img src="http://signatures.mylivesignature.com/54489/368/747C8ACDDDB7178899D9E6BAA765C3FC.png" style="border: 0 !important; background: transparent;"/></a>

    Comment

    • vivek_
      PhD Student
      • Jul 2012
      • 164

      #3
      I ended up creating a method using genotype quality scores and allele fractions form the GATK VCFs to identify candidate denovo mutations.

      Comment

      • rosa_dentellare
        Member
        • Sep 2011
        • 10

        #4
        Would you care to elaborate more Vivek? as I myself am also interested in looking at those accumulative and de novo variants.
        HTML Code:
        <a href="http://www.mylivesignature.com" target="_blank"><img src="http://signatures.mylivesignature.com/54489/368/747C8ACDDDB7178899D9E6BAA765C3FC.png" style="border: 0 !important; background: transparent;"/></a>

        Comment

        • trackavinash
          Member
          • Nov 2011
          • 14

          #5
          Hi,
          This is definitely a plug but I'd encourage you to check out our tool Denovogear which is designed to detect denovo mutations in trios using a Bayesian model that lets you set mutation rate priors and filter denovo calls based on posterior probabilities,
          Download DeNovoGear for free. DeNovoGear is a program to detect denovo mutations using sequencing data. The methods behind DeNovoGear are described in this publication, http://www.nature.com/nmeth/journal/v10/n10/full/nmeth.2611.html The production version of the code(updated more frequently) can be found here, https://github.com/denovogear/denovogear The releases of major and minor versions of the code are this Sourceforge page.

          Cheers,
          Avinash
          Last edited by trackavinash; 01-02-2013, 06:44 PM. Reason: typo.

          Comment

          • rosa_dentellare
            Member
            • Sep 2011
            • 10

            #6
            Thanks...will check d tool out =)
            HTML Code:
            <a href="http://www.mylivesignature.com" target="_blank"><img src="http://signatures.mylivesignature.com/54489/368/747C8ACDDDB7178899D9E6BAA765C3FC.png" style="border: 0 !important; background: transparent;"/></a>

            Comment

            • vivek_
              PhD Student
              • Jul 2012
              • 164

              #7
              I'd recommend Denovogear as well and I used it as part of my analysis.

              This publication was very helpful for me in formulating my other analysis methods:



              Some of the cut-offs and filters etc can be modified based on your read coverage.
              Last edited by vivek_; 01-03-2013, 08:48 AM.

              Comment

              • rosa_dentellare
                Member
                • Sep 2011
                • 10

                #8
                Thanks Vivek, appreciate it. Also, do you happen to have a copy for the paper?..I do not have access to Nature. Would appreciate that so much
                HTML Code:
                <a href="http://www.mylivesignature.com" target="_blank"><img src="http://signatures.mylivesignature.com/54489/368/747C8ACDDDB7178899D9E6BAA765C3FC.png" style="border: 0 !important; background: transparent;"/></a>

                Comment

                Latest Articles

                Collapse

                • SEQadmin2
                  Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
                  by SEQadmin2



                  CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

                  Despite this, “CRISPR helped turn genome editing from a specialized technique into
                  ...
                  07-31-2026, 11:01 AM
                • SEQadmin2
                  Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
                  by SEQadmin2


                  Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

                  The systematic characterization of the human proteome has
                  ...
                  07-20-2026, 11:48 AM
                • SEQadmin2
                  Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                  by SEQadmin2



                  Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                  ...
                  07-09-2026, 11:10 AM

                ad_right_rmr

                Collapse

                News

                Collapse

                Topics Statistics Last Post
                Started by SEQadmin2, Yesterday, 07:41 AM
                0 responses
                12 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 08-03-2026, 10:13 AM
                0 responses
                27 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 07-31-2026, 02:55 AM
                0 responses
                39 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 07-24-2026, 12:17 PM
                0 responses
                26 views
                0 reactions
                Last Post SEQadmin2  
                Working...